Heiligenstein, John H.

Results From 2 Proof-of-Concept, Placebo-Controlled Studies of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder

Spencer, T., Heiligenstein, J. H., Biederman, J., Faries, D. E., Kratochvil, C. J., Conners, C. K., & Potter, W. Z. (2002) · The Journal of Clinical Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 333

Atomoxetine and Methylphenidate Treatment in Children With ADHD: A Prospective, Randomized, Open-Label Trial

KRATOCHVIL, C. J., HEILIGENSTEIN, J. H., DITTMANN, R., SPENCER, T. J., BIEDERMAN, J., WERNICKE, J., NEWCORN, J. H., CASAT, C., MILTON, D., & MICHELSON, D. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 292

Cardiovascular Effects of Atomoxetine in Children, Adolescents, and Adults

Wernicke, J. F., Faries, D., Girod, D., Brown, J. W., Gao, H., Kelsey, D., Quintana, H., Lipetz, R., Michelson, D., & Heiligenstein, J. (2003) · Drug Safety

Attention Deficit Hyperactivity DisorderBlood Pressure and Hypertension Studies

Cited by 191

Is Baseline Agitation a Relative Contraindication for a Selective Serotonin Reuptake Inhibitor: A Comparative Trial of Fluoxetine Versus Imipramine

TOLLEFSON, G. D., GREIST, J. H., JEFFERSON, J. W., HEILIGENSTEIN, J. H., SAYLER, M. E., TOLLEFSON, S. L., & KOBACK, K. (1994) · Journal of Clinical Psychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 47

Safety of Subchronic Treatment with Fluoxetine for Major Depressive Disorder in Children and Adolescents

Nilsson, M., Joliat, M. J., Miner, C. M., Brown, E. B., & Heiligenstein, J. H. (2004) · Journal of Child and Adolescent Psychopharmacology

Treatment of Major DepressionChild and Adolescent Psychosocial and Emotional Development

Cited by 40

Fluoxetine 40–60 mg versus Fluoxetine 20 mg in the Treatment of Children and Adolescents with a Less-Than-Complete Response to Nine-Week Treatment with Fluoxetine 10–20 mg: APilot Study

Heiligenstein, J. H., Hoog, S. L., Wagner, K. D., Findling, R. L., Galil, N., Kaplan, S., Busner, J., Nilsson, M. E., Brown, E. B., & Jacobson, J. G. (2006) · Journal of Child and Adolescent Psychopharmacology

Treatment of Major DepressionChild and Adolescent Psychosocial and Emotional Development

Cited by 39